A 16-year prospective study of community -onset bacteremic acinetobacter pneumonia: Low mortality with appropriate initial empirical antibiotic protocols

Chest

Volumn 146, Issue 4, 2014, Pages 1038-1045

  Davis, Joshua S ^a,b   McMillan, Mark ^a   Swaminathan, Ashwin ^b   Kelly, John A ^b   Piera, Kim E ^a   Baird, Robert W ^b   Currie, Bart J ^a,b   Anstey, Nicholas M ^a,b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ACINETOBACTER NOSOCOMIALIS; ADULT; ALCOHOL CONSUMPTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTEREMIA; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMMUNITY ONSET ACINETOBACTER PNEUMONIA; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HUMAN; INDIGENOUS AUSTRALIAN; INTENSIVE CARE; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SEASONAL VARIATION; ACINETOBACTER INFECTIONS; AGED; COMMUNITY ACQUIRED INFECTION; CROSS INFECTION; DRUG EFFECTS; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, BACTERIAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES;

EID: 84907919353     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-3065     Document Type: Article

References (37)

1. Peleg AY, de Breij A, Adams MD, et al. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS One. 2012; 7 ( 10 ): e46984.
2. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007; 26 ( 12 ): 857 - 868.
3. Sebeny PJ, Riddle MS, Petersen K. Acinetobacter baumannii skin and soft -tissue infection associated with war trauma. Clin Infect Dis. 2008; 47 ( 4 ): 444 - 449.
4. Anstey NM, Currie BJ, Withnall KM. Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis. 1992; 14 ( 1 ): 83 - 91.
5. Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant communityacquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest. 2006; 129 ( 1 ): 102 - 109.
6. Ong CW, Lye DC, Khoo KL, et al. Severe community-acquired Acinetobacter baumannii pneumonia: An emerging highly lethal infectious disease in the Asia-Pacific. Respirology. 2009; 14 ( 8 ): 1200 - 1205.
7. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Severe communityacquired pneumonia due to Acinetobacter baumannii. Chest. 2001; 120 ( 4 ): 1072 - 1077.
8. Barnes DJ, Naraqi S, Igo JD. Communityacquired Acinetobacter pneumonia in adults in Papua New Guinea. Rev Infect Dis. 1988; 10 ( 3 ): 636 - 639.
9. Kang SJ, Kang CI, Park SY, et al. Epidemiology and clinical features of community-onset Acinetobacter baumannii infections. Infect Control Hosp Epidemiol. 2012; 33 ( 10 ): 1053 - 1055.
10. Wang JT, McDonald LC, Chang SC, Ho M. Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan. J Clin Microbiol. 2002; 40 ( 4 ): 1526 - 1529.
11. Vathesatogkit P, Charoenphan P, Saenghirunvattana S, Kiatboonsri S, Sathapatayavongs B. Communityacquired Acinetobacter pneumonia in Thailand. Report of 5 cases. J Med Assoc Thai. 1987; 70 ( 2 ): 96 - 101.
12. Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, withcarriage in the throat in at-risk groups. J Clin Microbiol. 2002; 40 ( 2 ): 685 - 686.
13. Friedman ND, Kaye KS, Stout JE, et al. Healthcare-associated bloodstream infections in adults: A reason to change the accepted definition of communityacquired infections. Ann Intern Med. 2002; 137 ( 10 ): 791 - 797.
14. National Healthand Medical Research Council. Australian Alcohol Guidelines: HealthRisks and Benefits. Canberra, Australia: National Healthand Medical Research Council; 2001.
15. Bernard GR, Vincent JL, Laterre PF, et al; Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001; 344 ( 10 ): 699 - 709.
16. Charles PG, Wolfe R, Whitby M, et al; Australian Community-Acquired Pneumonia Study Collaboration. SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support in communityacquired pneumonia. Clin Infect Dis. 2008; 47 ( 3 ): 375 - 384.
17. Nakamura T, Takahashi H. Screening of antibiotics resistance to Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii by an advanced expert system. J Infect Chemother. 2005; 11 ( 6 ): 288 - 292.
18. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol. 2010; 48 ( 12 ): 4592 - 4594.
19. Reijneveld SA. The choice of a statistic for testing hypotheses regarding seasonality. Am J Phys Anthropol. 1990; 83 ( 2 ): 181 - 184.
20. Chondur R, Wang Z, Guthridge S. Smoking Prevalence, Northern Territory Health Gains Planning Branch. Darwin, Australia : Northern Territory Government; 2010.
21. Condon J, Warman G, Arnold L. The Healthand Welfare of Territorians Epidemiology Branch. Darwin, Australia : Northern Territory Government; 2001.
22. Zhao Y, Connors C, Wright J, Guthridge S, Bailie R. Estimating chronic disease prevalence among the remote Aboriginal population of the Northern Territory using multiple data sources. Aust N Z J Public Health. 2008; 32 ( 4 ): 307 - 313.
23. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: The 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003; 178 ( 9 ): 427 - 432.
24. Elliott JH, Anstey NM, Jacups SP, Fisher DA, Currie BJ. Communityacquired pneumonia in northern Australia: Low mortality in a tropical region using locally-developed treatment guidelines. Int J Infect Dis. 2005; 9 ( 1 ): 15 - 20.
25. Yang Y, Yang KS, Hsann YM, Lim V, Ong BC. The effect of comorbidity and age on hospital mortality and lengthof stay in patients with sepsis. J Crit Care. 2010; 25 ( 3 ): 398 - 405.
26. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002; 122 ( 1 ): 262 - 268.
27. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: Link between quality of care and resource utilization. Arch Intern Med. 2002; 162 ( 6 ): 682 - 688.
28. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34 ( 6 ): 1589 - 1596.
29. Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009; 64 ( suppl 3 ): Iii1 - iii55.
30. Miyashita N, Matsushima T, Oka M; Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: An update and new recommendations. Intern Med. 2006; 45 ( 7 ): 419 - 428.
31. Davis JS, Cheng AC, McMillan M, Humphrey AB, Stephens DP, Anstey NM. Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians. Med J Aust. 2011; 194 ( 10 ): 519 - 524.
32. Edwards J, Patel G, Wareham DW. Low concentrations of commercial alcohol hand rubs facilitate growthof and secretion of extracellular proteins by multidrugresistant strains of Acinetobacter baumannii. J Med Microbiol. 2007; 56 ( pt 12 ): 1595 - 1599.
33. Nwugo CC, Arivett BA, Zimbler DL, Gaddy JA, Richards AM, Actis LA. Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii. PLoS One. 2012; 7 ( 12 ): e51936.
34. Camarena L, Bruno V, Euskirchen G, Poggio S, Snyder M. Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing. PLoS Pathog. 2010; 6 ( 4 ): e1000834.
35. Patel M, Keshavarzian A, Kottapalli V, Badie B, Winship D, Fields JZ. Human neutrophil functions are inhibited in vitro by clinically relevant ethanol concentrations. Alcohol Clin Exp Res. 1996; 20 ( 2 ): 275 - 283.
36. Asplund MB, Coelho C, Cordero RJ, Martinez LR. Alcohol impairs J774.16 macrophage-like cell antimicrobial functions in Acinetobacter baumannii infection. Virulence. 2013; 4 ( 6 ): 467 - 472.
37. Farrugia DN, Elbourne LD, Hassan KA, et al. The complete genome and phenome of a community-acquired Acinetobacter baumannii. PLoS One. 2013; 8 ( 3 ): e58628.